|
1
|
Kannan S, Shaik Syed Ali P, Sheeza A and
Hemalatha K: COVID-19 (Novel Coronavirus 2019) - recent trends. Eur
Rev Med Pharmacol Sci. 24:2006–2011. 2020.PubMed/NCBI
|
|
2
|
Pascarella G, Strumia A, Piliego C, Bruno
F, Del Buono R, Costa F, Scarlata S and Agrò FE3: COVID-19
diagnosis and management: A comprehensive review. J Intern Med.
288:192–206. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li H, Liu SM, Yu XH, Tang SL and Tang CK:
Coronavirus disease 2019 (COVID-19): Current status and future
perspectives. Int J Antimicrob Agents. 55:1059512020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Palacios Cruz M, Santos E, Velázquez
Cervantes MA and León Juárez M: COVID 19, a worldwide public health
emergency. Rev Clin Esp. 221:55–61. 2020.(In English and Spanish).
View Article : Google Scholar
|
|
5
|
Ortiz-Prado E, Espín E, Vásconez J,
Rodríguez-Burneo N, Kyriakidis NC and López-Cortés A: Vaccine
market and production capabilities in the Americas. Trop Dis Travel
Med Vaccines. 7:11. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kumar A, Dowling WE, Román RG, Chaudhari
A, Gurry C, Le TT, Tollefson S, Clark CE, Bernasconi V and
Kristiansen PA: Status Report on COVID-19 Vaccines Development.
Curr Infect Dis Rep. 23:9. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hu B, Guo H, Zhou P and Shi ZL:
Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol.
19:141–154. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu X, Chen P, Wang J, Feng J, Zhou H, Li
X, Zhong W and Hao P: Evolution of the novel coronavirus from the
ongoing Wuhan outbreak and modeling of its spike protein for risk
of human transmission. Sci China Life Sci. 63:457–460. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Astuti I and Ysrafil: Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of
viral structure and host response. Diabetes Metab Syndr.
14:407–412. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li W, Moore MJ, Vasilieva N, Sui J, Wong
SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough
TC, et al: Angiotensin-converting enzyme 2 is a functional receptor
for the SARS coronavirus. Nature. 426:450–454. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Turner AJ, Hiscox JA and Hooper NM: ACE2:
From vasopeptidase to SARS virus receptor. Trends Pharmacol Sci.
25:291–294. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song W, Gui M, Wang X and Xiang Y: Cryo EM
structure of the SARS coronavirus spike glycoprotein in complex
with its host cell receptor PLoS Pathog. 14:e10072362018.PubMed/NCBI
|
|
13
|
Verdecchia P, Cavallini C, Spanevello A
and Angeli F: The pivotal link between ACE2 deficiency and
SARS-CoV-2 infection. Eur J Intern Med. 76:14–20. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Santos RAS, Sampaio WO, Alzamora AC,
Motta-Santos D, Alenina N, Bader M and Campagnole-Santos MJ: The
ACE2/Angiotensin-(1–7)/MAS Axis of the Renin Angiotensin System:
Focus on Angiotensin-(1–7). Physiol Rev. 98:505–553. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou P, Yang XL, Wang XG, Hu B, Zhang L,
Zhang W, Si HR, Zhu Y, Li B, Huang CL, et al: A pneumonia outbreak
associated with a new coronavirus of probable bat origin. Nature.
579:270–273. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xia J, Tong J, Liu M, Shen Y and Guo D:
Evaluation of coronavirus in tears and conjunctival secretions of
patients with SARS CoV 2 infection. J Med Virol. 92:589–594. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Panoutsopoulos AA: Conjunctivitis as a
Sentinel of SARS-CoV-2 Infection: A Need of Revision for Mild
Symptoms. SN Compr Clin Med. 19:1–6. 2020.PubMed/NCBI
|
|
18
|
Aiello F, Gallo Afflitto G, Mancino R, Li
JO, Cesareo M, Giannini C and Nucci C: Coronavirus disease 2019
(SARS CoV 2) and colonization of ocular tissues and secretions: A
systematic review. Eye (Lond). 34:1206–1211. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Loffredo L, Pacella F, Pacella E, Tiscione
G, Oliva A and Violi F: Conjunctivitis and COVID 19: A meta
analysis. J Med Virol. 92:1413–1414. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Güemes-Villahoz N, Burgos-Blasco B,
García-Feijoó J, Sáenz-Francés F, Arriola-Villalobos P,
Martinez-de-la-Casa JM, Benítez-Del-Castillo JM and Herrera de la
Muela M: Conjunctivitis in COVID 19 patients: Frequency and
clinical presentation. Graefes Arch Clin Exp Ophthalmol.
58:2501–2507. 2020. View Article : Google Scholar
|
|
21
|
Ramos T, Scott D and Ahmad S: An update on
ocular surface epithelial stem cells: Cornea and conjunctiva. Stem
Cells Int. 2015:6017312015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pearson AA: The development of the
eyelids. Part I. External features. J Anat. 130:33–42.
1980.PubMed/NCBI
|
|
23
|
Zhang H, Hara M, Seki K, Fukuda K and
Nishida T: Eyelid fusion and epithelial differentiation at the
ocular surface during mouse embryonic development. Jpn J
Ophthalmol. 49:195–204. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ho D, Low R, Tong L, Gupta V,
Veeraraghavan A and Agrawal R: COVID 19 and the Ocular Surface: A
Review of transmission and manifestations. Ocul Immunol Inflamm.
28:726–734. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chu DK, Akl EA, Duda S, Solo K, Yaacoub S,
Schünemann HJ, Chu DK, Akl EA, El-harakeh A, Bognanni A, et al
COVID-19 Systematic Urgent Review Group Effort (SURGE) study
authors, : Physical distancing, face masks, and eye protection to
prevent person-to-person transmission of SARS-CoV-2 and COVID-19: A
systematic review and meta-analysis. Lancet. 395:1973–1987. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Leth-Larsen R, Zhong F, Chow VTK, Holmskov
U and Lu J: The SARS coronavirus spike glycoprotein is selectively
recognized by lung surfactant protein D and activates macrophages.
Immunobiology. 212:201–211. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao G, Hu M, Li C, Lee J, Yuan K, Zhu G
and Che C: Osteopontin contributes to effective neutrophil
recruitment, IL 1β production and apoptosis in Aspergillus
fumigatus keratitis. Immunol Cell Biol. 96:401–412. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Darnell MER, Subbarao K, Feinstone SM and
Taylor DR: Inactivation of the coronavirus that induces severe
acute respiratory syndrome, SARS-CoV. J Virol Methods. 121:85–91.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Menachery VD, Yount BL Jr, Debbink K,
Agnihothram S, Gralinski LE, Plante JA, Graham RL, Scobey T, Ge XY,
Donaldson EF, et al: A SARS-like cluster of circulating bat
coronaviruses shows potential for human emergence. Nat Med.
21:1508–1513. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu L, Sun Y, Pan X, Shen W, Liu ZY and
Liu YP: Expression of SARS CoVs protein functional receptor ACE2 in
human cornea and conjunctiva. Ophthalmic Res. 22:561–564. 2004.
|
|
32
|
Barnett BP, Wahlin K, Krawczyk M, Spencer
D, Welsbie D, Afshari N and Chao D: Potential of ocular
transmission of SARS-CoV-2: A Review. Vision (Basel).
4:42020.PubMed/NCBI
|
|
33
|
Kugadas A and Gadjeva M: Impact of
microbiome on ocular health. Ocul Surf. 14:342–349. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lu CW, Liu XF and Jia ZF: 2019-nCoV
transmission through the ocular surface must not be ignored.
Lancet. 395:e392020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cheema M, Aghazadeh H, Nazarali S, Ting A,
Hodges G, McFarlane A, Kanji J, Zelyas N, Damji K and Solarte C:
Keratoconjunctivitis as the initial medical presentation of the
novel coronavirus disease 2019 (COVID 19). Can J Ophthalmol.
55:e125–e129. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang W, Ye L, Ye L, Li B, Gao B, Zeng Y,
Kong L, Fang X, Zheng H, Wu Z, et al: Up-regulation of IL-6 and
TNF-alpha induced by SARS-coronavirus spike protein in murine
macrophages via NF-kappaB pathway. Virus Res. 128:1–8. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kovacs SB and Miao EA: Gasdermins:
Effectors of Pyroptosis. Trends Cell Biol. 27:673–684. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shi J, Gao W and Shao F: Pyroptosis:
Gasdermin-Mediated Programmed Necrotic Cell Death. Trends Biochem
Sci. 42:245–254. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xu YJ, Zheng L, Hu YW and Wang Q:
Pyroptosis and its relationship to atherosclerosis. Clin Chim Acta.
476:28–37. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Man SM, Karki R and Kanneganti TD:
Molecular mechanisms and functions of pyroptosis, inflammatory
caspases and inflammasomes in infectious diseases. Immunol Rev.
277:61–75. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhao W, Yang H, Lyu L, Zhang J, Xu Q,
Jiang N, Liu G, Wang L, Yan H and Che C: GSDMD, an executor of
pyroptosis, is involved in IL-1β secretion in Aspergillus fumigatus
keratitis. Exp Eye Res. 202:1083752021. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Miao EA, Rajan JV and Aderem A:
Caspase-1-induced pyroptotic cell death. Immunol Rev. 243:206–214.
2011. View Article : Google Scholar : PubMed/NCBI
|
